2,5-二乙基四氢呋喃 | 41239-48-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 四氢呋喃
• 中文名称: 2,5-二乙基四氢呋喃
• 英文名称: 2,5-diethoxytetrahydrofuran
• 英文别名: 2,5-diethyl tetrahydrofuran；2,5-diethyltetrahydrofuran；2,5-diethyl-tetrahydro-furan；2,5-Diaethyl-tetrahydro-furan；2,5-Diaethyl-tetrahydrofuran；2,5-Diaethyltetrahydrofuran；2,5-diethyloxolane
• CAS: 41239-48-9
• 化学式: C₈H₁₆O
• mdl: MFCD00236382
• 分子量: 128.214
• InChiKey: YKWLEIXVUHRKEF-UHFFFAOYSA-N

物化性质

• 沸点：
  197.67°C (rough estimate)
• 密度：
  0.8824 (rough estimate)
• 溶解度：
  氯仿（微溶）、甲醇（微溶）
• LogP：
  2.37
• 物理描述：
  Liquid
• 折光率：
  1.401-1.407
• 保留指数：
  884;884;916

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  9
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

ADMET

毒理性

• 副作用

神经毒素 - 急性溶剂综合征

Neurotoxin - Acute solvent syndrome

来源:Haz-Map, Information on Hazardous Chemicals and Occupational Diseases

安全信息

• 海关编码：
  2932190090

反应信息

• 作为反应物：
  描述：

  2,5-二乙基四氢呋喃 在 aluminum oxide 、 硫化氢 作用下， 生成 2,5-diethyl-tetrahydro-thiophene
  参考文献：
  名称：

  Jur'ew et al., Zhurnal Obshchei Khimii, 1952, vol. 22, p. 339,342, engl. Ausg. S. 405, 407, 409

  摘要：

  DOI：
• 作为产物：
  描述：

  4-辛炔-3,6-二醇 在 乙醇 、 硫酸 、 铂 作用下， 生成 2,5-二乙基四氢呋喃
  参考文献：
  名称：

  Jur'ew et al., Zhurnal Obshchei Khimii, 1952, vol. 22, p. 339,342, engl. Ausg. S. 405, 407, 409

  摘要：

  DOI：

文献信息

• BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF
  申请人：SENOMYX, INC.

  公开号：US20160376263A1

  公开（公告）日：2016-12-29

  The present invention includes compounds and compositions known to modify the perception of bitter taste, and combinations of said compositions and compounds with additional compositions, compounds, and products. Exemplary compositions comprise one or more of the following: cooling agents; inactive drug ingredients; active pharmaceutical ingredients; food additives or foodstuffs; flavorants, or flavor enhancers; food or beverage products; bitter compounds; sweeteners; bitterants; sour flavorants; salty flavorants; umami flavorants; plant or animal products; compounds known to be used in pet care products; compounds known to be used in personal care products; compounds known to be used in home products; pharmaceutical preparations; topical preparations; cannabis-derived or cannabis-related products; compounds known to be used in oral care products; beverages; scents, perfumes, or odorants; compounds known to be used in consumer products; silicone compounds; abrasives; surfactants; warming agents; smoking articles; fats, oils, or emulsions; and/or probiotic bacteria or supplements.

  本发明涵盖已知用于改变苦味感知的化合物和组合物，以及所述组合物和化合物与额外的组合物、化合物和产品的组合。示例组合物包括以下一种或多种：冷却剂；无活性药物成分；活性药用成分；食品添加剂或食品；调味剂或调味增强剂；食品或饮料产品；苦味化合物；甜味剂；苦味剂；酸味调味剂；咸味调味剂；鲜味调味剂；植物或动物产品；已知用于宠物护理产品中的化合物；已知用于个人护理产品中的化合物；已知用于家用产品中的化合物；制药制剂；局部制剂；大麻衍生或与大麻相关的产品；已知用于口腔护理产品中的化合物；饮料；香味、香水或除臭剂；已知用于消费品中的化合物；硅化合物；磨料；表面活性剂；发热剂；吸烟物品；脂肪、油脂或乳化剂；和/或益生菌或补充剂。
• [EN] COMPOSITIONS COMPRISING PHOSPHOINOSITIDE 3-KINASE INHIBITORS AND A SECOND ANTIPROLIFERATIVE AGENT<br/>[FR] COMPOSITIONS COMPRENANT DES INHIBITEURS DE LA PHOSPOINOSITIDE 3-KINASE ET UN SECOND AGENT ANTIPROLIFÉRATIF
  申请人：KARUS THERAPEUTICS LTD

  公开号：WO2017029517A1

  公开（公告）日：2017-02-23

  The invention relates to a pharmaceutical composition comprising a combination of a compound of formula (I) or a pharmaceutically acceptable salt thereof, and at least one second agent selected from the group consisting of signal transduction pathway inhibitors, tumour immunotherapeutics, agents inhibiting the BCL2 family of proteins, agents inhibiting Mcl-1, proteasome Inhibitors, poly (ADP-ribose) polymerase (PARP) Inhibitors, aromatase inhibitors, conventional cytotoxic agents or a miscellaneous agent selected from abiraterone, ARN-509 and MYC inhibitors.

  这项发明涉及一种药物组合物，包括化合物(I)或其药学上可接受的盐，以及从信号转导途径抑制剂、肿瘤免疫治疗药物、抑制BCL2蛋白家族的药物、抑制Mcl-1的药物、蛋白酶体抑制剂、聚(ADP核糖)聚合酶(PARP)抑制剂、芳香化酶抑制剂、传统细胞毒药物或从阿比特龙、ARN-509和MYC抑制剂中选择的杂项药物中选择的至少一种第二药剂。
• [EN] FRAGRANCE COMPOSITIONS COMPRISING COMPOUNDS WITH OLFACTORY QUALITIES<br/>[FR] COMPOSITIONS PARFUMÉES COMPRENANT DES COMPOSANTS AYANT DES QUALITÉS OLFACTIVES
  申请人：P2 SCIENCE INC

  公开号：WO2017139637A1

  公开（公告）日：2017-08-17

  The application relates to compositions comprising compounds of Formula I, Formula II, or Formula III and the use of these compositions in the fragrance industry, i.e., for the production of perfumes, air fresheners, laundry detergents, household cleaning products, liquid or bar soaps, shampoos, conditioners, hair sprays, cosmetics, deodorants, insect repellants, insecticides, and pet litter.

  该申请涉及包含式I、式II或式III化合物的组合物，以及这些组合物在香精行业中的应用，即用于生产香水、空气清新剂、洗衣液、家庭清洁产品、液体或固体肥皂、洗发水、护发素、发胶、化妆品、除臭剂、驱虫剂、杀虫剂和宠物猫砂。
• COMPOUNDS USEFUL AS MODULATORS OF TRPM8
  申请人：Senomyx, Inc.

  公开号：US20170096418A1

  公开（公告）日：2017-04-06

  The present disclosure relates to compounds which are useful as cooling sensation compounds.

  本公开涉及作为冷感化合物有用的化合物。
• DOUBLE PREPARATION TYPE ANTIOXIDANT COMPOSITION AND ANTIOXIDATION PRODUCT COMPRISING THE SAME
  申请人：Hirano Kyoko

  公开号：US20100074971A1

  公开（公告）日：2010-03-25

  It is to provide an antioxidant excellent in antioxidative potential and having high safety is provided. Also, it is to provide an antioxidant in which problems of unpleasant smell and taste are avoided and its preparation method is not so complex. Further, it is to provide an antioxidant which can exert its effect by a simple operation when exertion of the antioxidative potential is desired. It relates to a double preparation type antioxidant, which comprises a mixture A comprising a polyphenol and a mixture B comprising an alkali agent. In particular, two antioxidant component-storing containers are mutually integrally molded and combined, and a mixture A comprising a polyphenol is stored in one of the antioxidant component-storing containers and a mixture B comprising an alkali agent is stored in the other antioxidant component storing container.

  本发明提供了一种抗氧化剂，具有优异的抗氧化潜力和高度的安全性。此外，本发明还提供了一种避免了不愉快气味和味道问题的抗氧化剂，并且其制备方法并不复杂。此外，本发明还提供了一种能够通过简单操作发挥其抗氧化潜力的抗氧化剂。它涉及一种双重制备型抗氧化剂，包括混合物A，其中包括多酚和混合物B，其中包括碱性剂。特别地，两个抗氧化剂成分储存容器相互整体成型并组合在一起，其中一种抗氧化剂成分储存容器中存储多酚混合物A，另一种抗氧化剂成分储存容器中存储碱性剂混合物B。

表征谱图